AnalystsGeorge FarmerGeorge Farmer's Stock Forecasts
AnalystsGeorge Farmer
Sectors:
Industries:
Analyst Ranking
Bottom 7%
#4778 out of 5087 analysts
Average Return
-5.76%
Win Rate
44%21 out of 48
Risk vs Reward
Poor
Good
George Farmer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Pandion Therapeutics IncPAND | +219.76% | $18.78 | $60.05 | 2020-08-10 - 2021-03-31 | Buy |
Blueprint Medicines CorpBPMC | +82.07% | $57.77 | $105.18 | 2020-03-17 - 2021-03-17 | Buy |
Newamsterdam Pharma Co NvNAMS | +81.49% | $20.91 | $37.95 | 2025-02-27 - 2025-10-31 | Buy |
C4 Therapeutics IncCCCC | +74.68% | $25.71 | $44.91 | 2020-10-27 - 2021-10-26 | Buy |
Urogen Pharma LtdURGN | +70.16% | $12.03 | $20.47 | 2025-06-13 - 2025-10-31 | Buy |
George Farmer Analyst Color
Get additional color on George Farmer's coverage of popular stocks
George Farmer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biomea Fusion IncBMEA | 4 | Buy | $10.00 | +635.29% | Maintains | 3 months ago |
Arcellx IncACLX | 4 | Buy | $133.00 | +47.37% | Maintains | 3 months ago |
Sage Therapeutics IncSAGE | 6 | Hold | $9.20 | +5.99% | Downgrades | 4 months ago |
Inmune Bio IncINMB | 3 | Sell | $0.60 | -67.21% | Downgrades | 4 months ago |
Urogen Pharma LtdURGN | 1 | Buy | $47.00 | +129.60% | Maintains | 5 months ago |
Syndax Pharmaceuticals IncSNDX | 4 | Hold | $17.00 | +24.09% | Maintains | 6 months ago |
Protara Therapeutics IncTARA | 1 | Buy | $12.00 | +131.66% | Initiates Coverage On | 7 months ago |
Tempest Therapeutics IncTPST | 3 | Buy | $7.00 | -31.24% | Maintains | 7 months ago |
Adaptimmune Therapeutics PLCADAPY | 2 | Buy | $1.40 | +2,492.59% | Maintains | 7 months ago |
Janux Therapeutics IncJANX | 4 | Hold | $41.00 | +42.81% | Maintains | 8 months ago |
Newamsterdam Pharma Co NvNAMS | 4 | Buy | $52.00 | +37.02% | Maintains | 8 months ago |
Biomarin Pharmaceutical IncBMRN | 7 | Hold | $80.00 | +49.34% | Maintains | 8 months ago |
Biogen IncBIIB | 4 | Buy | $224.00 | +45.20% | Maintains | 9 months ago |
Viking Therapeutics IncVKTX | 1 | Buy | $102.00 | +167.86% | Initiates Coverage On | 9 months ago |
Kura Oncology IncKURA | 2 | Hold | $10.00 | -2.63% | Maintains | 10 months ago |
Argenx SeARGX | 5 | Buy | $715.00 | -12.65% | Upgrades | a year ago |
Aura Biosciences IncAURA | 2 | Buy | $23.00 | N/A | Maintains | a year ago |
Skye Bioscience IncSKYE | 1 | Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
Legend Biotech CorpLEGN | 4 | Buy | $76.00 | N/A | Maintains | a year ago |
Absci CorpABSI | 1 | Buy | $13.00 | N/A | Initiates Coverage On | 2 years ago |
Mirati Therapeutics IncMRTX | 3 | Hold | $58.00 | N/A | Upgrades | 2 years ago |
Moderna IncMRNA | 1 | Hold | $109.00 | N/A | Downgrades | 5 years ago |
C4 Therapeutics IncCCCC | 1 | Buy | $33.00 | N/A | Initiates Coverage On | 5 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 5 years ago |
Pandion Therapeutics IncPAND | 1 | Buy | $29.00 | N/A | Initiates Coverage On | 5 years ago |
Immunic IncIMUX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 5 years ago |
Seagen IncSGEN | 2 | Buy | $154.00 | N/A | Reiterates | 6 years ago |
Blueprint Medicines CorpBPMC | 2 | Buy | $89.00 | N/A | Upgrades | 6 years ago |
Exelixis IncEXEL | 1 | Hold | $20.00 | N/A | Maintains | 6 years ago |
Incyte CorpINCY | 1 | Hold | $74.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.